Los Angeles-based Cedars-Sinai is backing an artificial intelligence startup that scans EHR data to arm providers with clinical insights and potential diagnoses.
Cedars-Sinai Health Ventures was among the investors in a $61 million series B financing round July 11 for Regard, which already counts several health systems as clients. The startup has been valued at $350 million, TechCrunch reported.
"Cedars-Sinai has been working alongside Regard from the early days of the business because we saw a real need to empower physicians with the data that can provide critical analysis and insights to assist in diagnosis and treatment," said Maureen Burgess, partner at Cedars-Sinai Health Ventures, in a statement. "And, even more importantly, we believe it will improve patient care as well as the patient experience."
Regard's other health system customers include Phoenix-based Banner Health, Norfolk, Va.-based Sentara Health, and Raleigh, N.C.-based WakeMed. The company said it is at the vanguard of what comes next after AI scribes, revealing clinical insights from all that new EHR data.